Advertisement

Topics

Endocrinology Reports

03:36 EDT 26th September 2017 | BioPortfolio

Transdermal Drug Delivery Technologies, Markets, and Companies [Report Updated: 08092017] Prices from USD $3500

Benefits of this reportUptodate onestop information on transdermal drug deliveryDescription of 110 companies involved and 110 collaborations in this areaMarket analysis 20152025/Market values in major regionsStrategies for developing markets for transdermal drug deliveryA selected bibliography of 220 publicationsText is supplemented by 22 tables and 14 figuresWho should read this report?Biotechnol...

Global Follicle Stimulating Hormone Market Research Report 20112023 [Report Updated: 31082017] Prices from USD $1800

SummaryFollicle stimulating hormone FSH is a hormone made by the pituitary gland that affects the gonads female ovaries and males testes. In females, it stimulates growth of the ovarian follicles.The global Follicle Stimulating Hormone market will reach Volume Million USD in 2017 with CAGR xx% 20182023. The objective of report is to define, segment, and project the market on the basis of product t...

Steroid Hormone Receptor ERR1 Estrogen Receptor Like 1 or Estrogen Related Receptor Alpha or Nuclear Receptor Subfamily 3 Group B Member 1 or NR3B1 or ESRRA Pipeline Review, H2 2017 [Report Updated: 29082017] Prices from USD $3500

Steroid Hormone Receptor ERR1 Estrogen Receptor Like 1 or Estrogen Related Receptor Alpha or Nuclear Receptor Subfamily 3 Group B Member 1 or NR3B1 or ESRRA Pipeline Review, H2 2017SummaryAccording to the recently published report 'Steroid Hormone Receptor ERR1 Pipeline Review, H2 2017'; Steroid Hormone Receptor ERR1 Estrogen Receptor Like 1 or Estrogen Related Receptor Alpha or Nuclear Receptor...

Growth Hormone Antagonist Pipeline Insights, 2017 [Report Updated: 01092017] Prices from USD $1250

DelveInsight's, Growth Hormone AntagonistMechanism of action Insights, 2017, report provides comprehensive insights of the ongoing therapeutic research and development across Growth Hormone Antagonist. The report provides a complete understanding of the pipeline activities covering all clinical, preclinical and discovery stage products. A comparative pipeline therapeutics assessment of Growth Horm...

Peroxisome Proliferator Activated Receptor Delta NUCI or Nuclear Hormone Receptor 1 or Nuclear Receptor Subfamily 1 Group C Member 2 or Peroxisome Proliferator Activated Receptor Beta or NR1C2 or PPARD Pipeline Review, H2 2017 [Report Updated: 29082017]

Peroxisome Proliferator Activated Receptor Delta NUCI or Nuclear Hormone Receptor 1 or Nuclear Receptor Subfamily 1 Group C Member 2 or Peroxisome Proliferator Activated Receptor Beta or NR1C2 or PPARD Pipeline Review, H2 2017SummaryPeroxisome Proliferator Activated Receptor Delta NUCI or Nuclear Hormone Receptor 1 or Nuclear Receptor Subfamily 1 Group C Member 2 or Peroxisome Proliferator Activa...

Metastatic Hormone Refractory Prostate Cancer Market Insights, Epidemiology and Market Forecast 2025 [Report Updated: 31072017] Prices from USD $5750

DelveInsight's Metastatic Hormone Refractory Prostate Cancer Market Insights, Epidemiology and Market Forecast 2025 report provides an overview of the disease and in depth research related to Metastatic Hormone Refractory Prostate Cancer for the 7MM United States, Germany, France, Italy, Spain and UK for the study period undertaken from 20152025. This report provides understanding of the patie...

Millendo Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 22082017] Prices from USD $250

SummaryMillendo Therapeutics Inc Millendo Therapeutics, formerly Atterocor Inc develops treatments for endocrine diseases including vasomotor. The company provides development of innovative treatments for orphan endocrine disorders such as adrenocortical carcinoma caused by hormone abnormalities. Its pipeline products include MLE4901 and ATR101. Millendo Therapeutics' MLE4901 product is used for t...

OpportunityAnalyzer: Growth Hormone Deficiency Opportunity Analysis and Forecasts to 2026 [Report Updated: 12052017] Prices from USD $10995

OpportunityAnalyzer: Growth Hormone Deficiency Opportunity Analysis and Forecasts to 2026SummaryGrowth hormone deficiency GHD is a rare endocrine disorder characterized by inadequate secretion of growth hormone GH from the anterior pituitary gland. It is a heterogeneous disorder that may present in childhood pediatric GHD or later in adult life adult GHD. Reduced GH secretion predominantly result...

Global Human Growth Hormone Market Data Survey Report 2025 [Report Updated: 25072017] Prices from USD $1500

SummaryGrowth hormone GH, also known as somatotropin or as human growth hormone in its human form, is a peptide hormone that stimulates growth, cell reproduction, and cell regeneration in humans and other animals. It is thus important in human development. It is a type of mitogen which is specific only to certain kinds of cells. Growth hormone is a 191amino acid, singlechain polypeptide that is sy...

Pituitary ACTH Hypersecretion Cushing's Disease Pipeline Insight, 2017 [Report Updated: 31072017] Prices from USD $1250

DelveInsight's, Pituitary ACTH Hypersecretion Cushing's DiseasePipeline Insights, 2017, report provides comprehensive insights of the ongoing therapeutic research and development across Pituitary ACTH Hypersecretion Cushing's Disease. The report provides a complete understanding of the pipeline activities covering all clinical, preclinical and discovery stage products. A comparative pipeline thera...

Congenital Adrenal Hyperplasia Adrenogenital Syndrome Global Clinical Trials Review, H1, 2017 [Report Updated: 30062017] Prices from USD $2500

Congenital Adrenal Hyperplasia Adrenogenital Syndrome Global Clinical Trials Review, H1, 2017SummaryGlobalData's clinical trial report, Congenital Adrenal Hyperplasia Adrenogenital Syndrome Global Clinical Trials Review, H1, 2017" provides an overview of Congenital Adrenal Hyperplasia Adrenogenital Syndrome clinical trials scenario. This report provides top line data relating to the clinical trial...

Endo Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27072017] Prices from USD $250

SummaryEndo Pharmaceuticals Inc Endo Pharmaceuticals, a subsidiary of Endo International plc is a healthcare products provider that offers medicinal products. The company manufactures and distributes generic pharmaceutical products and overthecounter medications. Its products include testosterone undecanoate injection CIII, buprenorphine buccal film CIII, alprostadil for injection, testosterone ge...

Urea Cycle Disorders Market Insights, Epidemiology and Market Forecast 2025 [Report Updated: 31072017] Prices from USD $5750

DelveInsight's Urea Cycle Disorders Market Insights, Epidemiology and Market Forecast 2025 report provides an overview of the disease and in depth research related to Urea Cycle Disorders for the 7MM United States, Germany, France, Italy, Spain and UK for the study period undertaken from 20152025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends...

Metastatic Hormone Refractory Prostate Cancer Pipeline Insight, 2017 [Report Updated: 31072017] Prices from USD $1500

DelveInsight's, Metastatic Hormone Refractory Prostate CancerPipeline Insights, 2017, report provides comprehensive insights of the ongoing therapeutic research and development across Metastatic Hormone Refractory Prostate Cancer. The report provides a complete understanding of the pipeline activities covering all clinical, preclinical and discovery stage products. A comparative pipeline therapeut...

Urea Cycle Disorders Epidemiology Insights to 2025 [Report Updated: 31072017] Prices from USD $2950

DelveInsight's Urea Cycle Disorders Epidemiology Forecast, 2025 provides an overview of the epidemiology trends of Urea Cycle Disorders in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Urea Cycle Disorders. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unm...

Binge Eating Disorders Epidemiology Insights to 2025 [Report Updated: 10072017] Prices from USD $2950

DelveInsight Binge Eating Disorders Epidemiology Forecast To 2025 provides an overview of the epidemiology trends of Binge Eating Disorders in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Binge Eating Disorders prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses...

Male Hypogonadism Market by Therapy Testosterone Replacement therapy and Gonadotropin and GonadotropinReleasing Hormones Therapy Luteinizing Hormone LH, FollicleStimulating Hormone FSH, Human Chorionic Gonadotropin hCG, and GonadotropinReleasing Hormone G

Male hypogonadism is a medical condition characterized by the inability of the testes to produce sufficient amount of testosterone, which is responsible for the development of secondary sexual characteristics. This results in underdevelopment of muscles, impaired growth of body hair, development of breast tissues, and lack of deepening of the voice.nnThe global male hypogonadism market was valued ...

Global Human Growth Hormone Market Research 2011 2022 [Report Updated: 21042017] Prices from USD $2080

SummaryThe global Human Growth Hormone market is estimated to reach 3.6 Billion USD in 2017. The objective of report is to define, segment, and project the market on the basis of type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.Based on products type, the report describes major products type ...

Sleep Aids Market by Product Mattress Pillows, Sleep Laboratories, Medications, and Sleep Apnea Devices and Sleep Disorder Insomnia, Sleep Apnea, Restless Leg Syndrome, Narcolepsy, Sleep Walking, and Other Sleep Disorders Global Opportunity Analysis and

Sleep aids are drugs and devices that are used to diagnose and treat sleep disorders, such as sleep apnea and insomnia. Sleep disorders are caused due to substance misuse, stressful work environment, and inconsistent sleep pattern. Sleep aids help to improve the quality of sleep by reducing the time required to fall asleep and increasing the duration of quality sleep. The global sleep aids market ...

Hormone Replacement Therapy HRTGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2017 [Report Updated: 30052017] Prices from USD $1700

DelveInsight's Report, Hormone Replacement Therapy HRTGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Hormone Replacement Therapy HRT Report is to understand the market and pipeline status of the drugs around the...

Hormone Refractory Breast CancerGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2017 [Report Updated: 30052017] Prices from USD $1700

DelveInsight's Report, Hormone Refractory Breast CancerGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Hormone Refractory Breast Cancer Report is to understand the market and pipeline status of the drugs around t...

Metastatic Hormone Refractory Castration Resistant, AndrogenIndependent Prostate CancerGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2017 [Report Updated: 30052017] Prices from USD $1700

DelveInsight's Report, Metastatic Hormone Refractory Castration Resistant, AndrogenIndependent Prostate CancerGlobal API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Metastatic Hormone Refractory Castration Resistant, An...

GonadotropinReleasing Hormone GnRH Receptor LHRH Receptor Antagonists Pipeline Insights, 2017 [Report Updated: 30052017] Prices from USD $1063

DelveInsight's, GonadotropinReleasing Hormone GnRH Receptor LHRH Receptor AntagonistsPipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the GonadotropinReleasing Hormone GnRH Receptor LHRH Receptor Antagonists. The DelveInsight's Report covers the product profiles in various stages of development including Discovery, Preclinical...

Growth Hormone Antagonists Pipeline Insights, 2017 [Updated: 30052017] Prices from USD $1063

DelveInsight's, Growth Hormone AntagonistsPipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Growth Hormone Antagonists. The DelveInsight's Report covers the product profiles in various stages of development including Discovery, Preclinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product cli...

Hearing DisordersPipeline Insights, 2017 [Updated: 30052017] Prices from USD $1063

DelveInsight's, Hearing DisordersPipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Hearing Disorders. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Preclinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials info...

Quick Search
Advertisement
 

review and buy Endocrinology market research data and corporate reports here